Brain alteration of PCOS: neuroimaging and function - Scorecard - MDSpire

Brain alteration of PCOS: neuroimaging and function

  • By

  • Ningxiao Jiang

  • Jie Deng

  • Changjin Bao

  • Hongmei Yin

  • Xianghui Zhang

  • Yanxia Ding

  • Shinan Zhang

  • Yingjiang Xu

  • Xinghua Diao

  • Kexin Lu

  • Jun Liu

  • Lei Han

  • June 11, 2026

  • 0 min

Share

Clinical Scorecard: Neuroimaging and Functional Changes in the Brain Associated with Polycystic Ovary Syndrome

At a Glance

CategoryDetail
ConditionPolycystic Ovary Syndrome (PCOS)
Key MechanismsNeuroendocrine dysregulation involving the cerebral cortex and the hypothalamic-pituitary-ovarian axis.
Target PopulationWomen of reproductive age diagnosed with PCOS.
Care SettingClinical and research settings focusing on endocrine and neuroimaging studies.

Key Highlights

  • Enlargement of the pituitary gland and reduction in gray matter volume observed in PCOS patients.
  • Altered activity in the right orbitofrontal cortex linked to sympathetic activation.
  • Elevated μ-opioid receptor binding in emotion-related brain regions.
  • Structural and functional brain changes associated with abnormal glucose metabolism and cognitive/emotional alterations.
  • Dysfunction of limbic system circuitry may underlie affective and cognitive symptoms in PCOS.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis based on Rotterdam criteria, NIH criteria, or Androgen Excess Society criteria.

Management

  • Further investigations warranted to address unresolved mechanistic questions.

Monitoring & Follow-up

  • Monitor endocrine-metabolic profiles and behavioral patterns in PCOS patients.

Risks

  • Potential for cognitive and emotional changes linked to neuroimaging alterations.

Patient & Prescribing Data

Women diagnosed with PCOS.

Current investigations are limited; further research needed for targeted therapeutic strategies.

Clinical Best Practices

  • Utilize neuroimaging to assess structural and functional brain changes in PCOS.
  • Consider the interplay of neuroendocrine and metabolic factors in managing PCOS.

Related Resources & Content

    Original Source(s)

    Brain alteration of PCOS: neuroimaging and function

    • by Ningxiao Jiang, Jie Deng, Changjin Bao, Hongmei Yin, Xianghui Zhang, Yanxia Ding, Shinan Zhang, Yingjiang Xu, Xinghua Diao, Kexin Lu, Jun Liu, Lei Han

    • June 11, 2026

    Related Content

    Investigational Drug Shows Potentialin Phase 3 Obesity Trial

    In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.

    Gender differences in symptoms suggestive of diabetic gastroparesis in the West Bank: clinical insights from a cross-sectional study

    Higher-Dose Prenatal Vitamin D Linked to Memory Scores

    Children exposed to higher-dose prenatal vitamin D scored modestly higher on verbal and visual memory tests at age 10 years, although overall intelligence and most cognitive measures did not differ significantly.